Keywords: actelion, drops, emea, indication, extension, zavesca, european

Actelion drops EMEA indication extension for Zavesca

Article | 03 March 2008

Print This

The European Medicines Agency (EMEA) says it has been formally notified by Swiss drug firm Actelion of its decision to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in